|
1
|
Torre LA, Islami F, Siegel RL, Ward EM and
Jemal A: Global cancer in women: Burden and trends. Cancer
Epidemiol Biomarkers Prev. 26:444–457. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hernandez RK, Wade SW, Reich A, Pirolli M,
Liede A and Lyman GH: Incidence of bone metastases in patients with
solid tumors: Analysis of oncology electronic medical records in
the United States. BMC Cancer. 18:442018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kennecke H, Yerushalmi R, Woods R, Cheang
MC, Voduc D, Speers CH, Nielsen TO and Gelmon K: Metastatic
behavior of breast cancer subtypes. J Clin Oncol. 28:3271–3277.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coleman RE, Croucher PI, Padhani AR,
Clézardin P, Chow E, Fallon M, Guise T, Colangeli S, Capanna R and
Costa L: Bone metastases. Nat Rev Dis Primers. 6:832020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Waning DL and Guise TA: Molecular
mechanisms of bone metastasis and associated muscle weakness. Clin
Cancer Res. 20:3071–3077. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Weilbaecher KN, Guise TA and McCauley LK:
Cancer to bone: A fatal attraction. Nat Rev Cancer. 11:411–425.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wortzel I, Dror S, Kenific CM and Lyden D:
Exosome-mediated metastasis: Communication from a distance. Dev
Cell. 49:347–360. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Möller A and Lobb RJ: The evolving
translational potential of small extracellular vesicles in cancer.
Nat Rev Cancer. 20:697–709. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Théry C, Witwer KW, Aikawa E, Alcaraz MJ,
Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F,
Atkin-Smith GK, et al: Minimal information for studies of
extracellular vesicles 2018 (MISEV2018): A position statement of
the international society for extracellular vesicles and update of
the MISEV2014 guidelines. J Extracell Vesicles. 7:15357502018.
View Article : Google Scholar
|
|
11
|
Colombo M, Raposo G and Théry C:
Biogenesis, secretion, and intercellular interactions of exosomes
and other extracellular vesicles. Annu Rev Cell Dev Biol.
30:255–289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kalluri R and LeBleu VS: The biology,
function, and biomedical applications of exosomes. Science.
367:eaau69772020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dai J, Su Y, Zhong S, Cong L, Liu B, Yang
J, Tao Y, He Z, Chen C and Jiang Y: Exosomes: Key players in cancer
and potential therapeutic strategy. Signal Transduct Target Ther.
5:1452020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu M, Wang G, Hu W, Yao Y and Yu XF:
Emerging roles and therapeutic value of exosomes in cancer
metastasis. Mol Cancer. 18:532019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee TH, Chennakrishnaiah S, Audemard E,
Montermini L, Meehan B and Rak J: Oncogenic ras-driven cancer cell
vesiculation leads to emission of double-stranded DNA capable of
interacting with target cells. Biochem Biophys Res Commun.
451:295–301. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lobb RJ, Hastie ML, Norris EL, van
Amerongen R, Gorman JJ and Möller A: Oncogenic transformation of
lung cells results in distinct exosome protein profile similar to
the cell of origin. Proteomics. 17:16004322017. View Article : Google Scholar
|
|
17
|
Cha DJ, Franklin JL, Dou Y, Liu Q,
Higginbotham JN, Demory Beckler M, Weaver AM, Vickers K, Prasad N,
Levy S, et al: KRAS-dependent sorting of miRNA to exosomes. Elife.
4:e071972015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
McKenzie AJ, Hoshino D, Hong NH, Cha DJ,
Franklin JL, Coffey RJ, Patton JG and Weaver AM: KRAS-MEK signaling
controls Ago2 sorting into exosomes. Cell Rep. 15:978–987. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rochlitz CF, Scott GK, Dodson JM, Liu E,
Dollbaum C, Smith HS and Benz CC: Incidence of activating ras
oncogene mutations associated with primary and metastatic human
breast cancer. Cancer Res. 49:357–360. 1989.PubMed/NCBI
|
|
20
|
Galiè M: RAS as supporting actor in breast
cancer. Front Oncol. 9:11992019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wright KL, Adams JR, Liu JC, Loch AJ, Wong
RG, Jo CE, Beck LA, Santhanam DR, Weiss L, Mei X, et al: Ras
signaling is a key determinant for metastatic dissemination and
poor survival of luminal breast cancer patients. Cancer Res.
75:4960–4972. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng ZY, Tian L, Bu W, Fan C, Gao X, Wang
H, Liao YH, Li Y, Lewis MT, Edwards D, et al: Wild-type N-Ras,
overexpressed in basal-like breast cancer, promotes tumor formation
by inducing IL-8 secretion via JAK2 activation. Cell Rep.
12:511–524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Banys-Paluchowski M, Milde-Langosch K,
Fehm T, Witzel I, Oliveira-Ferrer L, Schmalfeldt B and Müller V:
Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in
primary breast cancer patients. Breast Cancer Res Treat.
179:403–414. 2020. View Article : Google Scholar
|
|
24
|
Gal M, Kim O, Tran PT, Huong LT, Nhiem NX,
Van Kiem P, Dang NH and Lee JH: Mussaendoside O, a N-triterpene
cycloartane saponin, attenuates RANKL-induced osteoclastogenesis
and inhibits lipopolysaccharide-induced bone loss. Phytomedicine.
105:1543782022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim O, Hwangbo C, Tran PT and Lee JH:
Syntenin-1-mediated small extracellular vesicles promotes cell
growth, migration, and angiogenesis by increasing onco-miRNAs
secretion in lung cancer cells. Cell Death Dis. 13:1222022.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luo J, Yang Z, Ma Y, Yue Z, Lin H, Qu G,
Huang J, Dai W, Li C, Zheng C, et al: LGR4 is a receptor for RANKL
and negatively regulates osteoclast differentiation and bone
resorption. Nat Med. 22:539–546. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hayashi M, Nakashima T, Taniguchi M,
Kodama T, Kumanogoh A and Takayanagi H: Osteoprotection by
semaphorin 3A. Nature. 485:69–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Z, Hao J, Duan X, Wu N, Zhou Z, Yang F,
Li J, Zhao Z and Huang S: The role of semaphorin 3A in bone
remodeling. Front Cell Neurosci. 11:402017.PubMed/NCBI
|
|
29
|
Mundy GR: Metastasis to bone: Causes,
consequences and therapeutic opportunities. Nat Rev Cancer.
2:584–593. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jabbari N, Akbariazar E, Feqhhi M,
Rahbarghazi R and Rezaie J: Breast cancer-derived exosomes: Tumor
progression and therapeutic agents. J Cell Physiol. 235:6345–6356.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yuan X, Qian N, Ling S, Li Y, Sun W, Li J,
Du R, Zhong G, Liu C, Yu G, et al: Breast cancer exosomes
contribute to pre-metastatic niche formation and promote bone
metastasis of tumor cells. Theranostics. 11:1429–1445. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo L, Zhu Y, Li L, Zhou S, Yin G, Yu G
and Cui H: Breast cancer cell-derived exosomal miR-20a-5p promotes
the proliferation and differentiation of osteoclasts by targeting
SRCIN1. Cancer Med. 8:5687–5701. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Arciero CA, Guo Y, Jiang R, Behera M,
O'Regan R, Peng L and Li X: ER+/HER2+ breast cancer has different
metastatic patterns and better survival than ER-/HER2+ breast
cancer. Clin Breast Cancer. 19:236–245. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Faversani A, Amatori S, Augello C, Colombo
F, Porretti L, Fanelli M, Ferrero S, Palleschi A, Pelicci PG,
Belloni E, et al: miR-494-3p is a novel tumor driver of lung
carcinogenesis. Oncotarget. 8:7231–7247. 2017. View Article : Google Scholar :
|
|
35
|
Wu C, Yang J, Li R, Lin X and Wu J and Wu
J: LncRNA WT1-AS/miR-494-3p regulates cell proliferation,
apoptosis, migration and invasion via PTEN/PI3K/AKT signaling
pathway in non-small cell lung cancer. Onco Targets Ther.
14:891–904. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He H, Liao X, Yang Q, Liu Y, Peng Y, Zhong
H, Yang J, Zhang H, Yu Z, Zuo Y, et al: MicroRNA-494-3p promotes
cell growth, migration, and invasion of nasopharyngeal carcinoma by
targeting Sox7. Technol Cancer Res Treat. 17:15330338188099932018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Behar O, Golden JA, Mashimo H, Schoen FJ
and Fishman MC: Semaphorin III is needed for normal patterning and
growth of nerves, bones and heart. Nature. 383:525–528. 1996.
View Article : Google Scholar : PubMed/NCBI
|
